These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

81 related items for PubMed ID: 1544845

  • 1. Phase I study of BW12C in combination with mitomycin C in patients with advanced gastrointestinal cancer.
    Ramsay JR, Bleehen NM, Dennis I, Workman P, Ward R, Falk SJ, Bedford P, Wootton R, Nethersell AB.
    Int J Radiat Oncol Biol Phys; 1992; 22(4):721-5. PubMed ID: 1544845
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. BW12C perturbs normal and tumour tissue oxygenation and blood flow in man.
    Falk SJ, Ramsay JR, Ward R, Miles K, Dixon AK, Bleehen NM.
    Radiother Oncol; 1994 Sep; 32(3):210-7. PubMed ID: 7816940
    [Abstract] [Full Text] [Related]

  • 4. Phase II study of the oxygen saturation curve left shifting agent BW12C in combination with the hypoxia activated drug mitomycin C in advanced colorectal cancer.
    Propper DJ, Levitt NC, O'Byrne K, Braybrooke JP, Talbot DC, Ganesan TS, Thompson CH, Rajagopalan B, Littlewood TJ, Dixon RM, Harris AL.
    Br J Cancer; 2000 Jun; 82(11):1776-82. PubMed ID: 10839290
    [Abstract] [Full Text] [Related]

  • 5. A phase I study of the left-shifting agent BW12C79 plus mitomycin C and the effect on the skeletal muscle metabolism using 31P magnetic resonance spectroscopy.
    Philip PA, Thompson CH, Carmichael J, Rea D, Mitchell K, Taylor DJ, Stuart NS, Dennis I, Rajagopalan B, Ganesan T.
    Cancer Res; 1993 Dec 01; 53(23):5649-53. PubMed ID: 8242619
    [Abstract] [Full Text] [Related]

  • 6. Inefficacy of dacarbazine, mitomycin C, and hepatic irradiation in patients with metastatic adenocarcinoma of the gastrointestinal tract.
    Smith BJ, Evans M, Hellmann K, Jones R, Newton K, Peters N, Phillips RH.
    J Clin Oncol; 1984 Jun 01; 2(6):578-80. PubMed ID: 6427420
    [Abstract] [Full Text] [Related]

  • 7. Mitomycin C and menadione for the treatment of advanced gastrointestinal cancers: a phase II trial.
    Tetef M, Margolin K, Ahn C, Akman S, Chow W, Coluzzi P, Leong L, Morgan RJ, Raschko J, Shibata S.
    J Cancer Res Clin Oncol; 1995 Jun 01; 121(2):103-6. PubMed ID: 7883772
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Protection of pig epidermis against radiation-induced damage by the infusion of BW12C.
    van den Aardweg GJ, Hopewell JW, Adams GE, Barnes DW, Sansom JM, Stratford IJ, Nethersell AB.
    Int J Radiat Biol; 1991 Apr 01; 59(4):1039-51. PubMed ID: 1674270
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. 5-Fluorouracil, high-dose folinic acid, and mitomycin C combination chemotherapy in advanced gastrointestinal adenocarcinomas. A pilot study.
    Becouarn Y, Brunet R, Bussières E, Marée D.
    Oncology; 1988 Apr 01; 45(4):269-72. PubMed ID: 3133620
    [Abstract] [Full Text] [Related]

  • 12. Phase II study of continuous 120-hour-infusion of mitomycin C as salvage chemotherapy in patients with progressive or rapidly recurrent gastrointestinal adenocarcinoma.
    Hartmann JT, Kanz L, Bokemeyer C.
    Anticancer Res; 2000 Apr 01; 20(2B):1177-82. PubMed ID: 10810418
    [Abstract] [Full Text] [Related]

  • 13. Effects of an increase in haemoglobin O2 affinity produced by BW12C on myocardial function in the erythrocyte-perfused rabbit heart in vitro and myocardial infarct size in the dog.
    Allan G, Chapple DJ, Hughes B.
    Br J Pharmacol; 1986 Sep 01; 89(1):183-90. PubMed ID: 3801772
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetic characteristics of 5-fluorouracil and mitomycin C in intraperitoneal chemotherapy.
    Kuzuya T, Yamauchi M, Ito A, Hasegawa M, Hasegawa T, Nabeshima T.
    J Pharm Pharmacol; 1994 Aug 01; 46(8):685-9. PubMed ID: 7815285
    [Abstract] [Full Text] [Related]

  • 15. The effects in volunteers of BW12C, a compound designed to left-shift the blood-oxygen saturation curve.
    Fitzharris P, McLean AE, Sparks RG, Weatherley BC, White RD, Wootton R.
    Br J Clin Pharmacol; 1985 Apr 01; 19(4):471-81. PubMed ID: 3994894
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Mitomycin C and Vinorelbine for second-line chemotherapy in NSCLC--a phase II trial.
    Babiak A, Hetzel J, Godde F, König HH, Pietsch M, Hetzel M.
    Br J Cancer; 2007 Apr 10; 96(7):1052-6. PubMed ID: 17353918
    [Abstract] [Full Text] [Related]

  • 19. [Evaluation of a combination of UFT, MMC, and OK-432 for advanced gastro-intestinal cancer].
    Misawa S, Yashige H, Nishigaki H, Horiike S, Tsuda S, Abe T, Takino T, Taniwaki M, Takeda S, Tsuji T.
    Nihon Gan Chiryo Gakkai Shi; 1987 Dec 20; 22(10):2427-35. PubMed ID: 3130449
    [No Abstract] [Full Text] [Related]

  • 20. Concurrent mitomycin C, 5-fluorouracil, and radiotherapy in the treatment of locally advanced carcinoma of the cervix: a randomized trial.
    Lorvidhaya V, Chitapanarux I, Sangruchi S, Lertsanguansinchai P, Kongthanarat Y, Tangkaratt S, Visetsiri E.
    Int J Radiat Oncol Biol Phys; 2003 Apr 01; 55(5):1226-32. PubMed ID: 12654431
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.